| Original language | English (US) |
|---|---|
| Pages (from-to) | 1174-1177 |
| Number of pages | 4 |
| Journal | Leukemia |
| Volume | 27 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2013 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma : A Children's Oncology Group report. / Goldman, S.; Smith, L.; Anderson, J. R.; Perkins, S.; Harrison, L.; Geyer, M. B.; Gross, T. G.; Weinstein, H.; Bergeron, S.; Shiramizu, B.; Sanger, W.; Barth, M.; Zhi, J.; Cairo, M. S.
In: Leukemia, Vol. 27, No. 5, 05.2013, p. 1174-1177.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma
T2 - A Children's Oncology Group report
AU - Goldman, S.
AU - Smith, L.
AU - Anderson, J. R.
AU - Perkins, S.
AU - Harrison, L.
AU - Geyer, M. B.
AU - Gross, T. G.
AU - Weinstein, H.
AU - Bergeron, S.
AU - Shiramizu, B.
AU - Sanger, W.
AU - Barth, M.
AU - Zhi, J.
AU - Cairo, M. S.
N1 - Funding Information: VG, KF and MH received honoraria and travel grants from Roche. MH declared consultancy and board membership for Roche. GB, KH and MW are paid employees of Roche. The remaining authors declare no conflict of interest. Funding Information: We thank Linda Rahl, Virginia Davenport and Saumya Pachauri for their assistance in the development and conduct of this trial, and Ms Amber Quinlan and Erin Morris, RN, for their editorial assistance in the development of this manuscript. We would also like to thank Dr James Lynch for his assistance with analyzing the data. This research was funded by the Division of Cancer Treatment, National Cancer Institute, and National Institutes of Health, Department of Health and Human Services (COG) (CA98543-09 and CA98413-09), Pediatric Cancer Research Foundation and the Doris Duke Charitable Foundation. NCI provided support for data collection and analysis, but had no role in data interpretation, writing of the manuscript or the decision on journal submission.
PY - 2013/5
Y1 - 2013/5
UR - http://www.scopus.com/inward/record.url?scp=84877619828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877619828&partnerID=8YFLogxK
U2 - 10.1038/leu.2012.255
DO - 10.1038/leu.2012.255
M3 - Letter
C2 - 22940833
AN - SCOPUS:84877619828
VL - 27
SP - 1174
EP - 1177
JO - Leukemia
JF - Leukemia
SN - 0887-6924
IS - 5
ER -